Perpetual Ltd’s United Therapeutics UTHR Stock Holding History

Perpetual Ltd’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$381K	Hold	704	–	–	0.01%	338
2026 Q2	$381K	Sell	704 -513	-42%	-$289K	0.01%	374
2026 Q1	$722K	Sell	1,217 -957	-44%	-$477K	0.01%	261
2025 Q4	$1.06M	Buy	+2,174	New	+$1.01M	0.02%	232
2025 Q1	–	Sell	-1,170	Closed	-$413K	–	440
2024 Q4	$413K	Buy	1,170 +448	+62%	+$165K	﹤0.01%	344
2024 Q3	$259K	Buy	+722	New	+$244K	﹤0.01%	384
2024 Q2	–	Sell	-1,178	Closed	-$271K	–	474
2024 Q1	$271K	Buy	+1,178	New	+$266K	﹤0.01%	401

Other funds holding UTHR

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.9B AUM 30.31% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Seizert Capital Partners Birmingham, Michigan $2.3B AUM 16.06% 1-Year Est. Return

Perpetual Ltd's UTHR Position: Q3 2026 in Review

Perpetual Ltd held its United Therapeutics (UTHR) position steady in Q3 2026 at 704 shares worth $381K. The position accounts for 0.01% of the portfolio, ranked #338.

Perpetual Ltd first reported a position in UTHR in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.06M in Q4 2025. 329 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

Perpetual Ltd held 704 shares of United Therapeutics worth $381K as of Q3 2026.
Perpetual Ltd left its United Therapeutics share count unchanged in Q3 2026.
United Therapeutics made up 0.01% of Perpetual Ltd's portfolio in Q3 2026, its #338 holding.
Perpetual Ltd first reported a position in United Therapeutics in Q1 2024 and has held it in 7 quarters since.
Perpetual Ltd's United Therapeutics position peaked at $1.06M in Q4 2025.
329 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Perpetual Ltd's 13F filing for Q3 2026, filed 13 Oct 2026.